Addus HomeCare (NASDAQ:ADUS) Shares Gap Down – Time to Sell?

Addus HomeCare Corporation (NASDAQ:ADUS) gapped down prior to trading on Tuesday . The stock had previously closed at $117.63, but opened at $107.27. Addus HomeCare shares last traded at $108.0950, with a volume of 156,773 shares traded.

Addus HomeCare News Roundup

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Revenue and top‑line growth — Net service revenues rose ~25.6% to about $373M, showing strong organic/acquisition growth that supports the company’s longer‑term scale story. Addus HomeCare Announces Fourth Quarter and Year End 2025 Financial Results
• Positive Sentiment: Adjusted earnings and profitability improvement — Adjusted EPS was reported up ~28% to $1.77 and adjusted EBITDA increased ~33%, indicating operating leverage as revenue grows. This was called out as an outperform vs. some estimates. Addus HomeCare (ADUS) Beats Q4 Earnings and Revenue Estimates
• Positive Sentiment: Margin and cash‑flow progress — Management reported higher gross and operating margins and stronger cash from operations year‑over‑year, which supports sustainable profitability as revenue scales. Addus HomeCare Corporation (ADUS) Releases Q4 2025 Earnings: Strong Revenue Growth but EPS Miss
• Neutral Sentiment: Consensus vs. reported — Several sources describe the quarter as roughly in‑line: revenue and EPS were close to Wall Street expectations (tiny variances across data providers), so the print was not a clear blowout. Addus HomeCare beats estimates on earnings and revenue
• Neutral Sentiment: Analyst positioning — Boutique upgrades and a string of buy/outperform ratings remain in place; median analyst targets sit well above current levels (mid‑$130s to $140s), giving upside if growth continues. Addus HomeCare Corporation (ADUS) Releases Q4 2025 Earnings: Strong Revenue Growth but EPS Miss
• Negative Sentiment: Mixed/contradictory beats vs. misses — Some data providers reported small misses to consensus (a few million on revenue and modest EPS differences), creating confusion and causing some investors to trim positions. Addus HomeCare Corporation (ADUS) Releases Q4 2025 Earnings: Strong Revenue Growth but EPS Miss
• Negative Sentiment: Insider selling and institutional churn — Recent filings show insider sales and notable institutional position changes in recent quarters, which can weigh on sentiment when the quarter is only modestly ahead/around expectations. Addus HomeCare Corporation (ADUS) Releases Q4 2025 Earnings: Strong Revenue Growth but EPS Miss

Analysts Set New Price Targets

Several research firms recently weighed in on ADUS. BMO Capital Markets began coverage on Addus HomeCare in a research note on Thursday, November 13th. They issued a “market perform” rating and a $120.00 price target on the stock. Royal Bank Of Canada upped their price target on shares of Addus HomeCare from $134.00 to $139.00 and gave the stock an “outperform” rating in a research report on Friday, November 7th. Truist Financial set a $135.00 price target on shares of Addus HomeCare and gave the stock a “buy” rating in a research note on Wednesday, January 7th. Wall Street Zen upgraded shares of Addus HomeCare from a “buy” rating to a “strong-buy” rating in a report on Monday. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, January 21st. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $134.89.

Addus HomeCare Trading Down 10.2%

The firm has a market capitalization of $1.95 billion, a PE ratio of 22.55, a price-to-earnings-growth ratio of 1.39 and a beta of 0.91. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.14. The company’s 50-day simple moving average is $109.84 and its 200 day simple moving average is $113.15.

Institutional Trading of Addus HomeCare

Several hedge funds and other institutional investors have recently made changes to their positions in ADUS. Global Retirement Partners LLC increased its position in Addus HomeCare by 395.7% during the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock valued at $25,000 after buying an additional 186 shares in the last quarter. Larson Financial Group LLC raised its holdings in shares of Addus HomeCare by 133.3% in the third quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock worth $28,000 after buying an additional 136 shares during the last quarter. Acumen Wealth Advisors LLC purchased a new stake in Addus HomeCare during the 4th quarter valued at about $29,000. Private Trust Co. NA increased its stake in shares of Addus HomeCare by 65.5% in the fourth quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after acquiring an additional 112 shares during the period. Finally, Arax Advisory Partners grew its holdings in Addus HomeCare by 95.8% during the fourth quarter. Arax Advisory Partners now owns 280 shares of the company’s stock worth $30,000 after acquiring an additional 137 shares during the period. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.